ReviewFrontiers in oncology2014
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma.
Fabio M Iwamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it
ReviewFrontiers in oncology2014
Fabio M Iwamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.